-
Something wrong with this record ?
Randomized trial of primary PCI with or without routine manual thrombectomy
SS. Jolly, JA. Cairns, S. Yusuf, B. Meeks, J. Pogue, MJ. Rokoss, S. Kedev, L. Thabane, G. Stankovic, R. Moreno, A. Gershlick, S. Chowdhary, S. Lavi, K. Niemelä, PG. Steg, I. Bernat, Y. Xu, WJ. Cantor, CB. Overgaard, CK. Naber, AN. Cheema, RC....
Language English Country United States
Document type Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
NLK
ProQuest Central
from 1980-01-03 to 3 months ago
Nursing & Allied Health Database (ProQuest)
from 1980-01-03 to 3 months ago
Health & Medicine (ProQuest)
from 1980-01-03 to 3 months ago
Family Health Database (ProQuest)
from 1980-01-03 to 3 months ago
Psychology Database (ProQuest)
from 1980-01-03 to 3 months ago
Health Management Database (ProQuest)
from 1980-01-03 to 3 months ago
Public Health Database (ProQuest)
from 1980-01-03 to 3 months ago
PubMed
25853743
DOI
10.1056/nejmoa1415098
Knihovny.cz E-resources
- MeSH
- Stroke etiology MeSH
- Electrocardiography MeSH
- Myocardial Infarction complications therapy MeSH
- Kaplan-Meier Estimate MeSH
- Cardiovascular Diseases mortality prevention & control MeSH
- Combined Modality Therapy adverse effects MeSH
- Percutaneous Coronary Intervention * adverse effects MeSH
- Coronary Thrombosis complications therapy MeSH
- Middle Aged MeSH
- Humans MeSH
- Microvessels MeSH
- Aged MeSH
- Heart Failure etiology MeSH
- Thrombectomy * adverse effects MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Research Support, Non-U.S. Gov't MeSH
- Randomized Controlled Trial MeSH
BACKGROUND: During primary percutaneous coronary intervention (PCI), manual thrombectomy may reduce distal embolization and thus improve microvascular perfusion. Small trials have suggested that thrombectomy improves surrogate and clinical outcomes, but a larger trial has reported conflicting results. METHODS: We randomly assigned 10,732 patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary PCI to a strategy of routine upfront manual thrombectomy versus PCI alone. The primary outcome was a composite of death from cardiovascular causes, recurrent myocardial infarction, cardiogenic shock, or New York Heart Association (NYHA) class IV heart failure within 180 days. The key safety outcome was stroke within 30 days. RESULTS: The primary outcome occurred in 347 of 5033 patients (6.9%) in the thrombectomy group versus 351 of 5030 patients (7.0%) in the PCI-alone group (hazard ratio in the thrombectomy group, 0.99; 95% confidence interval [CI], 0.85 to 1.15; P=0.86). The rates of cardiovascular death (3.1% with thrombectomy vs. 3.5% with PCI alone; hazard ratio, 0.90; 95% CI, 0.73 to 1.12; P=0.34) and the primary outcome plus stent thrombosis or target-vessel revascularization (9.9% vs. 9.8%; hazard ratio, 1.00; 95% CI, 0.89 to 1.14; P=0.95) were also similar. Stroke within 30 days occurred in 33 patients (0.7%) in the thrombectomy group versus 16 patients (0.3%) in the PCI-alone group (hazard ratio, 2.06; 95% CI, 1.13 to 3.75; P=0.02). CONCLUSIONS: In patients with STEMI who were undergoing primary PCI, routine manual thrombectomy, as compared with PCI alone, did not reduce the risk of cardiovascular death, recurrent myocardial infarction, cardiogenic shock, or NYHA class IV heart failure within 180 days but was associated with an increased rate of stroke within 30 days. (Funded by Medtronic and the Canadian Institutes of Health Research; TOTAL ClinicalTrials.gov number, NCT01149044.).
Dante Pazzanese Institute of Cardiology São Paulo
Duke Clinical Research Institute Durham NC
Heart Center Tampere University Hospital Tampere Finland
Northeast Clinical Trials Group Scranton PA
Royal North Shore Hospital Sydney
the Tenth People's Hospital Tongji University Shanghai China
University Clinic of Cardiology Sts Cyril and Methodius University Skopje Macedonia
University Hospital and Faculty of Medicine Pilsen Pilsen both in the Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15022774
- 003
- CZ-PrNML
- 005
- 20220106083344.0
- 007
- ta
- 008
- 150709s2015 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1056/NEJMoa1415098 $2 doi
- 035 __
- $a (PubMed)25853743
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Jolly, Sanjit S $u From the Population Health Research Institute and Department of Medicine, McMaster University and Hamilton Health Sciences, Hamilton, ON (S.S.J., S.Y., B.M., J.P., M.J.R., L.T., M.K.N., O.S., P.G.), University of British Columbia, Vancouver (J.A.C.), London Health Sciences Centre, Department of Medicine, London, ON (S.L.), Southlake Regional Health Centre, Newmarket, ON (W.J.C.), Peter Munk Cardiac Centre, University Health Network (C.B.O., V.D.), and St. Michael's Hospital (A.N.C.), Toronto, Mazankowski Alberta Heart Institute, Department of Medicine, Edmonton (R.C.W.), and Quebec Heart-Lung Institute, Laval University, Quebec, QC (O.F.B.) - all in Canada; University Clinic of Cardiology, Sts. Cyril and Methodius University, Skopje, Macedonia (S.K.); Clinical Center of Serbia and Department of Cardiology, Medical Faculty, University of Belgrade, Belgrade, Serbia (G.S.); University Hospital La Paz, Madrid (R.M.); University Hospitals of Leicester, Department of Cardiovascular Sciences, Leicester (A.G.), and University Hospitals South Manchester, Manchester Academic Health Science Centre, Manchester (S.C.) - both in the United Kingdom; Heart Center, Tampere University Hospital, Tampere, Finland (K.N.); Université Paris-Diderot, Sorbonne Paris-Cité, INSERM Unité 1148, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Paris (P.G.S.); University Hospital and Faculty of Medicine Pilsen, Pilsen (I.B.), and the Third Faculty of Medicine, Charles University Prague, University Hospital Kralovske Vinohrady, Prague (P.W.) - both in the Czech Republic; the Tenth People's Hospital, Tongji University, Shanghai, China (Y.X.); Department of Cardiology and Angiology, Contilla Heart and Vascular Center, Elisabeth-Krankenhaus, Essen, Germany (C.K.N.); Dante Pazzanese Institute of Cardiology, São Paulo (A.A.); Royal North Shore Hospital, Sydney (R.B.); Northeast Clinical Trials Group, Scranton, PA (S.P.); Duke Clinical Research Institute, Durham, NC (S.V.R.); and Department
- 245 10
- $a Randomized trial of primary PCI with or without routine manual thrombectomy / $c SS. Jolly, JA. Cairns, S. Yusuf, B. Meeks, J. Pogue, MJ. Rokoss, S. Kedev, L. Thabane, G. Stankovic, R. Moreno, A. Gershlick, S. Chowdhary, S. Lavi, K. Niemelä, PG. Steg, I. Bernat, Y. Xu, WJ. Cantor, CB. Overgaard, CK. Naber, AN. Cheema, RC. Welsh, OF. Bertrand, A. Avezum, R. Bhindi, S. Pancholy, SV. Rao, MK. Natarajan, JM. ten Berg, O. Shestakovska, P. Gao, P. Widimsky, V. Džavík, . ,
- 520 9_
- $a BACKGROUND: During primary percutaneous coronary intervention (PCI), manual thrombectomy may reduce distal embolization and thus improve microvascular perfusion. Small trials have suggested that thrombectomy improves surrogate and clinical outcomes, but a larger trial has reported conflicting results. METHODS: We randomly assigned 10,732 patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary PCI to a strategy of routine upfront manual thrombectomy versus PCI alone. The primary outcome was a composite of death from cardiovascular causes, recurrent myocardial infarction, cardiogenic shock, or New York Heart Association (NYHA) class IV heart failure within 180 days. The key safety outcome was stroke within 30 days. RESULTS: The primary outcome occurred in 347 of 5033 patients (6.9%) in the thrombectomy group versus 351 of 5030 patients (7.0%) in the PCI-alone group (hazard ratio in the thrombectomy group, 0.99; 95% confidence interval [CI], 0.85 to 1.15; P=0.86). The rates of cardiovascular death (3.1% with thrombectomy vs. 3.5% with PCI alone; hazard ratio, 0.90; 95% CI, 0.73 to 1.12; P=0.34) and the primary outcome plus stent thrombosis or target-vessel revascularization (9.9% vs. 9.8%; hazard ratio, 1.00; 95% CI, 0.89 to 1.14; P=0.95) were also similar. Stroke within 30 days occurred in 33 patients (0.7%) in the thrombectomy group versus 16 patients (0.3%) in the PCI-alone group (hazard ratio, 2.06; 95% CI, 1.13 to 3.75; P=0.02). CONCLUSIONS: In patients with STEMI who were undergoing primary PCI, routine manual thrombectomy, as compared with PCI alone, did not reduce the risk of cardiovascular death, recurrent myocardial infarction, cardiogenic shock, or NYHA class IV heart failure within 180 days but was associated with an increased rate of stroke within 30 days. (Funded by Medtronic and the Canadian Institutes of Health Research; TOTAL ClinicalTrials.gov number, NCT01149044.).
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a kardiovaskulární nemoci $x mortalita $x prevence a kontrola $7 D002318
- 650 _2
- $a kombinovaná terapie $x škodlivé účinky $7 D003131
- 650 _2
- $a koronární trombóza $x komplikace $x terapie $7 D003328
- 650 _2
- $a elektrokardiografie $7 D004562
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a srdeční selhání $x etiologie $7 D006333
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a Kaplanův-Meierův odhad $7 D053208
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mikrocévy $7 D055806
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a infarkt myokardu $x komplikace $x terapie $7 D009203
- 650 12
- $a koronární angioplastika $x škodlivé účinky $7 D062645
- 650 _2
- $a cévní mozková příhoda $x etiologie $7 D020521
- 650 12
- $a trombektomie $x škodlivé účinky $7 D017131
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Cairns, John A
- 700 1_
- $a Yusuf, Salim
- 700 1_
- $a Meeks, Brandi
- 700 1_
- $a Pogue, Janice
- 700 1_
- $a Rokoss, Michael J
- 700 1_
- $a Kedev, Sasko
- 700 1_
- $a Thabane, Lehana
- 700 1_
- $a Stankovic, Goran
- 700 1_
- $a Moreno, Raul
- 700 1_
- $a Gershlick, A. H., $d 1951-2020 $7 xx0268075
- 700 1_
- $a Chowdhary, Saqib
- 700 1_
- $a Lavi, Shahar
- 700 1_
- $a Niemelä, Kari
- 700 1_
- $a Steg, Philippe Gabriel
- 700 1_
- $a Bernat, Ivo
- 700 1_
- $a Xu, Yawei
- 700 1_
- $a Cantor, Warren J
- 700 1_
- $a Overgaard, Christopher B
- 700 1_
- $a Naber, Christoph K
- 700 1_
- $a Cheema, Asim N
- 700 1_
- $a Welsh, Robert C
- 700 1_
- $a Bertrand, Olivier F
- 700 1_
- $a Avezum, Alvaro $7 gn_A_00010338
- 700 1_
- $a Bhindi, Ravinay
- 700 1_
- $a Pancholy, Samir
- 700 1_
- $a Rao, Sunil V
- 700 1_
- $a Natarajan, Madhu K
- 700 1_
- $a ten Berg, Jurriën M
- 700 1_
- $a Shestakovska, Olga
- 700 1_
- $a Gao, Peggy
- 700 1_
- $a Widimsky, Petr
- 700 1_
- $a Džavík, Vladimír
- 700 1_
- $a ,
- 773 0_
- $w MED00003517 $t The New England journal of medicine $x 1533-4406 $g Roč. 372, č. 15 (2015), s. 1389-98
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25853743 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150709 $b ABA008
- 991 __
- $a 20220106083340 $b ABA008
- 999 __
- $a ok $b bmc $g 1083113 $s 905767
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 372 $c 15 $d 1389-98 $i 1533-4406 $m The New England journal of medicine $n N Engl J Med $x MED00003517
- LZP __
- $a Pubmed-20150709